Phase I Trial of Intensity-Modulated Hyperfractionated Radiotherapy Boost with Concurrent Chemotherapy Immediately Following Standard Chemoradiotherapy in Patients Primarily with Advanced Intra-thoracic/Cervical Esophageal Squamous Cell Carcinomas

MLA

Ge Yan, et al. “Phase I Trial of Intensity-Modulated Hyperfractionated Radiotherapy Boost with Concurrent Chemotherapy Immediately Following Standard Chemoradiotherapy in Patients Primarily with Advanced Intra-Thoracic/Cervical Esophageal Squamous Cell Carcinomas.” International Journal of Radiation Oncology, Biology, Physics, vol. 106, no. 2, Apr. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6709430a324749b391f5cb6606216004&authtype=sso&custid=ns315887.

APA

Ge Yan, Wang Zijie, Tingfeng Chen, Ye Hu, Yi Xu, Yong Liu, Zhekai Hu, Dongli Liu, Chungang Wang, Z. Chen, Ying Chen, Shengyu Yao, T. Zhang, Ningning Cheng, & Guoqi Zhao. (2019). Phase I Trial of Intensity-Modulated Hyperfractionated Radiotherapy Boost with Concurrent Chemotherapy Immediately Following Standard Chemoradiotherapy in Patients Primarily with Advanced Intra-thoracic/Cervical Esophageal Squamous Cell Carcinomas. International Journal of Radiation Oncology, Biology, Physics, 106(2).

Chicago

Ge Yan, Wang Zijie, Tingfeng Chen, Ye Hu, Yi Xu, Yong Liu, Zhekai Hu, et al. 2019. “Phase I Trial of Intensity-Modulated Hyperfractionated Radiotherapy Boost with Concurrent Chemotherapy Immediately Following Standard Chemoradiotherapy in Patients Primarily with Advanced Intra-Thoracic/Cervical Esophageal Squamous Cell Carcinomas.” International Journal of Radiation Oncology, Biology, Physics 106 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6709430a324749b391f5cb6606216004&authtype=sso&custid=ns315887.